Search

everythinglearnresearchcommunity

for

Search:↓

Higher androgen levels during puberty are linked to shorter adult height in boys with Silver-Russell syndrome.

Girls conceived via assisted reproductive technologies show early puberty signs and larger ovaries.

Certain ESR1 gene variations may affect hormone levels and fat distribution in women with high male hormone levels.

Men with male pattern baldness may have a higher risk of heart disease due to increased levels of a specific lipid in their blood.

Finasteride effectively lowers specific hormone levels, helping monitor treatment progress.

Lower vaspin levels in the blood may indicate a better response to fertility treatment in women with PCOS.

Women with PCOS have lower amylin levels, which are not related to their body weight.

DHEA improved brain function and behavior in old monkeys and had additional health benefits.

Women with androgenetic alopecia (hair loss) have normal prostate specific antigen levels but higher testosterone levels.

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.

DHEA acts like a male hormone on rat skin glands and doesn't turn into female hormones there.

Women with PCOS have lower adiponectin hormone levels and are more likely to have insulin resistance.

Weight loss and metformin don't significantly change vaspin levels in women with PCOS.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Clinical signs of excess male hormones and actual hormone levels in the blood do not always match in women with polycystic ovary syndrome.

Certain genetic variations in the AR and ERβ genes can affect androgen levels in women.

Excessive hair growth can be assessed by history, exam, and blood tests, and treated with medication like dexamethasone, birth control pills, and spironolactone.

The conclusion is that accurately identifying the cause of high androgen levels in women with PCOS is crucial and requires specific tests.

Women with mild acne are more likely to have polycystic ovary syndrome (PCOS) than those without acne.

Blood tests are needed to confirm high male hormone levels in women with PCOS, as physical signs alone are not reliable.

Women with low SHBG levels and a high 3a-diol G to SHBG ratio are likely to experience female pattern baldness, possibly due to a slight excess of androgens affecting sensitive hair bulbs.

Women with PCOS have similar bone density to healthy women, but those who are obese have higher bone density at some body sites.

Ultrasound measurement of the ovarian stroma to total area ratio is not a reliable single predictor of high male hormone levels in Thai women with PCOS, but works better when combined with clinical signs.

A woman with high testosterone and an adrenal nodule had an ovarian tumor causing her symptoms, which improved after the tumor was removed.

Blood tests can detect ovarian Leydig cell tumors when scans don't, and surgery can confirm and treat these tumors.

Orlistat helped reduce weight and testosterone in obese women with PCOS but did not significantly affect other androgens or cholesterol levels.

Ovarian vein sampling helped diagnose rare ovarian tumors causing high testosterone, and surgery to remove the tumors lowered the testosterone levels.

An 84-year-old woman's hair loss was due to a rare condition called Leydig cell hyperplasia, which was treated with surgery.

High androgen levels in young women with PCOS are linked to higher blood pressure.

Certain gene variations are linked to a higher risk of severe acne, suggesting a genetic influence on the condition.